SIGMAPHARM LABS LLC
GenericsSIGMAPHARM LABS LLC is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Immunology.
SIGMAPHARM LABS LLC's Key Drugs
SIGMAPHARM LABS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SIGMAPHARM LABS LLC's Recent FDA Approvals
New NDA/BLA approvals for SIGMAPHARM LABS LLC over the last two years — novel drugs only, excluding generics and label supplements.
SIGMAPHARM LABS LLC's Therapeutic Areas
SIGMAPHARM LABS LLC's approved drugs and pipeline span 4 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SIGMAPHARM LABS LLC's Top Competitors
SIGMAPHARM LABS LLC's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and LEDERLE. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SIGMAPHARM LABS LLC Pipeline Snapshot
Active clinical trials for SIGMAPHARM LABS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2009-01-30
- Latest
- 2026-03-27
- Applications
- 18